BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34823522)

  • 21. Primary Gleason pattern in biopsy Gleason score 7 is predictive of adverse histopathological features and biochemical failure following radical prostatectomy.
    Berg KD; Røder MA; Brasso K; Vainer B; Iversen P
    Scand J Urol; 2014 Apr; 48(2):168-76. PubMed ID: 23889119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores.
    Seisen T; Roudot-Thoraval F; Bosset PO; Beaugerie A; Allory Y; Vordos D; Abbou CC; De La Taille A; Salomon L
    World J Urol; 2015 Jun; 33(6):787-92. PubMed ID: 24985552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.
    Helpap B; Ringli D; Tonhauser J; Poser I; Breul J; Gevensleben H; Seifert HH
    Pathol Oncol Res; 2016 Apr; 22(2):349-56. PubMed ID: 26563277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and design of the CANARI study: a case-control study investigating the association between prostate cancer and 5-alpha-reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific region in France.
    Scailteux LM; Balusson F; Vincendeau S; Rioux-Leclercq N; Nowak E
    Fundam Clin Pharmacol; 2018 Feb; 32(1):120-129. PubMed ID: 28856711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6.
    Wang H; Gu L; Wu Y; Feng D; Duan J; Wang X; Huang Y; Wu S; Chen J; Luo G; Zhang X
    BMC Cancer; 2017 Sep; 17(1):629. PubMed ID: 28874127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can transrectal ultrasound-guided biopsy of the prostate with extended 14-core scheme improve the predictive accuracy of Gleason score and tumor site in prostate cancer treatment?
    Dell'Atti L
    J BUON; 2015; 20(5):1239-43. PubMed ID: 26537070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Documentation quality of histopathology reports of prostate needle biopsies: a snapshot].
    Biesterfeld S
    Urologe A; 2014 Nov; 53(11):1644-50. PubMed ID: 25272987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
    Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
    Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment tables predicting pathologic stage of locally advanced prostate cancer.
    Joniau S; Spahn M; Briganti A; Gandaglia G; Tombal B; Tosco L; Marchioro G; Hsu CY; Walz J; Kneitz B; Bader P; Frohneberg D; Tizzani A; Graefen M; van Cangh P; Karnes RJ; Montorsi F; van Poppel H; Gontero P;
    Eur Urol; 2015 Feb; 67(2):319-25. PubMed ID: 24684960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
    Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two-Center Validation Study.
    Dell'Oglio P; Karnes RJ; Gandaglia G; Fossati N; Stabile A; Moschini M; Cucchiara V; Zaffuto E; Karakiewicz PI; Suardi N; Montorsi F; Briganti A
    Prostate; 2017 Feb; 77(3):263-273. PubMed ID: 27753114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy].
    Zuo Q; Zhang F; Huang Y; Ma LL; Lu M; Lu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):603-606. PubMed ID: 29263497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepancies Between Biopsy Gleason Score and Radical Prostatectomy Specimen Gleason Score: An Iranian Experience.
    Dolatkhah S; Mirtalebi M; Daneshpajouhnejad P; Barahimi A; Mazdak H; Izadpanahi MH; Mohammadi M; Taheri D
    Urol J; 2019 Feb; 16(1):56-61. PubMed ID: 30345499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
    Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
    Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional greyscale transrectal ultrasound-guidance and biopsy core preembedding for detection of prostate cancer: Dutch clinical cohort study.
    van der Aa AAMA; Mannaerts CK; Gayet MCW; van der Linden JC; Schrier BP; Sedelaar JPM; Mischi M; Beerlage HP; Wijkstra H
    BMC Urol; 2019 Apr; 19(1):23. PubMed ID: 30991993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perineural invasion on biopsy is associated with upstaging at radical prostatectomy in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Morash C; Bateman J; Mai KT; Belanger EC; Robertson SJ; Breau RH
    Pathol Int; 2016 Nov; 66(11):629-632. PubMed ID: 27709739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.